Literature DB >> 25785061

The expression and correlation of SIRT1 and Phospho-SIRT1 in colorectal cancer.

Xianzhen Zhang1, Suiqin Chen2, Meili Cheng3, Fangli Cao1, Yufeng Cheng4.   

Abstract

SIRT1 is the homologue of sir2 in mammals, which is a nicotinamide adenine dinucleotide (NAD(+)) dependent histone deacetylase. SIRT1 is involved in many physiological processes, such as metabolism, senescence, inflammatory response, neuroprotection, and tumorigenesis by acetylating histones and multiple transcription factors. However, the exact role of SIRT1 in tumor is still under controversial. Immunohistochemistry and Western blot were performed to investigate the expressions and subcellular localizations of SIRT1 and Phospho-SIRT1 in colorectal cancer tissues and adjacent normal tissues. The relationship between SIRT1 or Phospho-SIRT1 and clinicopathological characteristics was also analyzed. Real-Time PCR was performed to investigate the transcriptional level of SIRT1 mRNA in colorectal cancer tissues and adjacent normal tissues. SIRT1 and Phospho-SIRT1 were both localized in the nucleus. The expressions of SIRT1 and Phospho-SIRT1 were higher in colorectal cancer tissues than normal tissues. SIRT1 expression in cancer tissues was associated with patient age, TNM stage and mutant P53 loss. Phospho-SIRT1 expression in cancer tissues was associated with Ki67. SIRT1 and Phospho-SIRT1 were highly correlated in cancer tissues and normal tissues. The ratios of Phospho-SIRT1 and SIRT1 expression in cancer tissues were higher than normal tissues. SIRT1 mRNA level was no significant difference in cancer tissues and normal tissues. SIRT1 have a dual character in colorectal cancer, and Phospho-SIRT1 may determine the role of SIRT1 in colorectal cancer formation.

Entities:  

Keywords:  Ki67; P53; Phospho-SIRT1; SIRT1; colorectal cancer

Year:  2015        PMID: 25785061      PMCID: PMC4358516     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  39 in total

Review 1.  Are sirtuins viable targets for improving healthspan and lifespan?

Authors:  Joseph A Baur; Zoltan Ungvari; Robin K Minor; David G Le Couteur; Rafael de Cabo
Journal:  Nat Rev Drug Discov       Date:  2012-06-01       Impact factor: 84.694

2.  SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2.

Authors:  Barrie Peck; Chun-Yuan Chen; Ka-Kei Ho; Paolo Di Fruscia; Stephen S Myatt; R Charles Coombes; Matthew J Fuchter; Chwan-Deng Hsiao; Eric W-F Lam
Journal:  Mol Cancer Ther       Date:  2010-04-06       Impact factor: 6.261

3.  SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis.

Authors:  V Byles; L Zhu; J D Lovaas; L K Chmilewski; J Wang; D V Faller; Y Dai
Journal:  Oncogene       Date:  2012-01-16       Impact factor: 9.867

4.  Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1.

Authors:  Masaya Tanno; Jun Sakamoto; Tetsuji Miura; Kazuaki Shimamoto; Yoshiyuki Horio
Journal:  J Biol Chem       Date:  2006-12-30       Impact factor: 5.157

5.  SIRT1 and SIRT5 activity expression and behavioral responses to calorie restriction.

Authors:  Yi-Qun Geng; Tian-Ti Li; Xiang-Yu Liu; Zhao-Hui Li; Yu-Cai Fu
Journal:  J Cell Biochem       Date:  2011-12       Impact factor: 4.429

6.  JNK1 phosphorylates SIRT1 and promotes its enzymatic activity.

Authors:  Nargis Nasrin; Virendar K Kaushik; Eric Fortier; Daniel Wall; Kevin J Pearson; Rafael de Cabo; Laura Bordone
Journal:  PLoS One       Date:  2009-12-22       Impact factor: 3.240

7.  Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice.

Authors:  Rui-Hong Wang; Kundan Sengupta; Cuiling Li; Hyun-Seok Kim; Liu Cao; Cuiying Xiao; Sangsoo Kim; Xiaoling Xu; Yin Zheng; Beverly Chilton; Rong Jia; Zhi-Ming Zheng; Ettore Appella; Xin Wei Wang; Thomas Ried; Chu-Xia Deng
Journal:  Cancer Cell       Date:  2008-10-07       Impact factor: 31.743

Review 8.  Sirtuins in mammals: insights into their biological function.

Authors:  Shaday Michan; David Sinclair
Journal:  Biochem J       Date:  2007-05-15       Impact factor: 3.857

9.  SIRT1 is significantly elevated in mouse and human prostate cancer.

Authors:  Derek M Huffman; William E Grizzle; Marcas M Bamman; Jeong-su Kim; Isam A Eltoum; Ada Elgavish; Tim R Nagy
Journal:  Cancer Res       Date:  2007-07-15       Impact factor: 12.701

10.  Inhibition of Casein kinase-2 induces p53-dependent cell cycle arrest and sensitizes glioblastoma cells to tumor necrosis factor (TNFα)-induced apoptosis through SIRT1 inhibition.

Authors:  D Dixit; V Sharma; S Ghosh; V S Mehta; E Sen
Journal:  Cell Death Dis       Date:  2012-02-09       Impact factor: 8.469

View more
  7 in total

Review 1.  Role of Post-translational Modification of Silent Mating Type Information Regulator 2 Homolog 1 in Cancer and Other Disorders.

Authors:  Yeon-Hwa Lee; Su-Jung Kim; Young-Joon Surh
Journal:  J Cancer Prev       Date:  2022-09-30

2.  SIRT1 controls cell proliferation by regulating contact inhibition.

Authors:  Elizabeth H Cho; Yan Dai
Journal:  Biochem Biophys Res Commun       Date:  2016-08-08       Impact factor: 3.575

3.  miR-133b inhibits glioma cell proliferation and invasion by targeting Sirt1.

Authors:  Chuntao Li; Zhixiong Liu; Kui Yang; Xin Chen; Yu Zeng; Jinfang Liu; Zhenyan Li; Yunsheng Liu
Journal:  Oncotarget       Date:  2016-06-14

4.  Suppressive effect of microRNA-138 on the proliferation and invasion of osteosarcoma cells via targeting SIRT1.

Authors:  Zhenchao Yuan; Hao Mo; Ligen Mo; Juliang He; Zhenjie Wu; Xiang Lin
Journal:  Exp Ther Med       Date:  2017-05-04       Impact factor: 2.447

5.  MicroRNA-9 inhibits the proliferation and migration of malignant melanoma cells via targeting sirituin 1.

Authors:  Pingyuan Bu; Chengqun Luo; Quanyong He; Ping Yang; Xi Li; Dan Xu
Journal:  Exp Ther Med       Date:  2017-06-13       Impact factor: 2.447

Review 6.  Non-coding RNAs and glioblastoma: Insight into their roles in metastasis.

Authors:  Seyed Mojtaba Mousavi; Maryam Derakhshan; Fatereh Baharloii; Fatemeh Dashti; Seyed Mohammad Ali Mirazimi; Maryam Mahjoubin-Tehran; Saereh Hosseindoost; Pouya Goleij; Neda Rahimian; Michael R Hamblin; Hamed Mirzaei
Journal:  Mol Ther Oncolytics       Date:  2021-12-22       Impact factor: 7.200

7.  JNK-mediated Ser27 phosphorylation and stabilization of SIRT1 promote growth and progression of colon cancer through deacetylation-dependent activation of Snail.

Authors:  Yeon-Hwa Lee; Su-Jung Kim; Xizhu Fang; Na-Young Song; Do-Hee Kim; Jinyoung Suh; Hye-Kyung Na; Kyung-Ok Kim; Jeong-Heum Baek; Young-Joon Surh
Journal:  Mol Oncol       Date:  2022-01-04       Impact factor: 6.603

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.